Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update
17 août 2021 07h45 HE
|
Protagenic Therapeutics, Inc.
NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders,...